PharVision Advisers’s Under Armour UAA Stock Holding History

PharVision Advisers’s Portfolio UAA Stock Details UAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58,270	Closed	-$290K	–	615
2025 Q4	$290K	Buy	58,270 +38,750	+199%	+$179K	0.15%	289
2025 Q3	$97.4K	Buy	+19,520	New	+$114K	0.05%	625

Other funds holding UAA

FFH

Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PharVision Advisers's UAA Position: Q1 2026 in Review

PharVision Advisers sold out of Under Armour (UAA) in Q1 2026, closing a stake of 58,270 shares — an estimated $290K sold.

PharVision Advisers first reported a position in UAA in Q3 2025 and held it in 2 quarters. The position peaked at $290K in Q4 2025. 372 funds tracked by Wall St. Rank hold UAA as of Q1 2026.

PharVision Advisers reported no remaining Under Armour position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 58,270 Under Armour shares in Q1 2026, an estimated $290K.
PharVision Advisers first reported a position in Under Armour in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Under Armour position peaked at $290K in Q4 2025.
372 funds tracked by Wall St. Rank held Under Armour as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.